{"id":13572,"date":"2026-11-10T12:20:35","date_gmt":"2026-11-10T03:20:35","guid":{"rendered":"https:\/\/kojihifu.com\/english\/?p=13572"},"modified":"2026-11-10T12:20:36","modified_gmt":"2026-11-10T03:20:36","slug":"aga-finasteride-minoxidil-regenerative-tokyo-4","status":"publish","type":"post","link":"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo-4\/","title":{"rendered":"AGA Tokyo: Finasteride, Minoxidil &#038; Regenerative Options"},"content":{"rendered":"<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"MedicalWebPage\",\"@id\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/#webpage\",\"url\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/\",\"name\":\"AGA Tokyo: Finasteride, Minoxidil & Regenerative Options\",\"inLanguage\":\"en\",\"isPartOf\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#website\"},\"about\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#clinic-biotope\"},\"reviewedBy\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#physician-karibe\"},\"lastReviewed\":\"2026-11-10\"},{\"@type\":[\"Article\",\"MedicalWebPage\"],\"@id\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/#webpage\"},\"headline\":\"AGA Tokyo: Finasteride, Minoxidil & Regenerative Options\",\"url\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/\",\"inLanguage\":\"en\",\"author\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#physician-karibe\"},\"reviewedBy\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#physician-karibe\"},\"publisher\":{\"@id\":\"https:\/\/kojihifu.com\/english\/#organization\"},\"mainEntityOfPage\":{\"@id\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/#webpage\"},\"description\":\"AGA hair loss progresses without treatment. Explore finasteride, minoxidil & regenerative hair alternatives at Tokyo clinics. Book a consultation today.\",\"datePublished\":\"2026-11-10\",\"dateModified\":\"2026-11-10\",\"lastReviewed\":\"2026-11-10\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kojihifu.com\/english\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skin & Dermatology\",\"item\":\"https:\/\/kojihifu.com\/english\/column\/skin-dermatology\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"AGA Tokyo: Finasteride, Minoxidil & Regenerative Options\",\"item\":\"https:\/\/kojihifu.com\/english\/aga-finasteride-minoxidil-regenerative-tokyo\/\"}]}]}<\/script><br \/>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"Can I combine finasteride or minoxidil with PRP?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Yes. Combination approaches are well-supported in clinical literature. Pharmacotherapy addresses the hormonal driver (DHT suppression or vascular stimulation), while PRP provides growth factor stimulation to the follicle environment. Studies suggest that adding PRP to standard medications improves hair density and thickness more than either intervention alone. Your physician at BIOTOPE CLINIC can advise on scheduling and protocols for your specific situation.\"}}, {\"@type\": \"Question\", \"name\": \"How long before I see results from PRP for hair loss?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Most patients in clinical trials noticed measurable improvement at three to six months after their first session. Because hair cycles are inherently slow \u2014 the anagen phase for scalp hair lasts two to six years \u2014 the full response to an initial course of three to four monthly sessions is typically evaluated at six to nine months. Visible change before twelve weeks is uncommon, and patience is an essential part of the process.\"}}, {\"@type\": \"Question\", \"name\": \"Is exosome therapy for AGA covered by Japan's health insurance?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"No. Exosome and stem-cell-derived treatments are conducted in Japan under the Act on the Safety of Regenerative Medicine and fall entirely outside the national health insurance scheme. They are self-pay, and costs should be confirmed with the treating clinic at consultation. This is true for all AGA pharmacotherapy as well \u2014 finasteride and minoxidil are also self-pay in Japan.\"}}, {\"@type\": \"Question\", \"name\": \"I am a woman experiencing hair thinning. Are these treatments relevant?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Female-pattern hair loss (FAGA) has a distinct hormonal profile from male AGA, and oral finasteride is not indicated for women of childbearing potential in Japan. Topical minoxidil does have evidence in female-pattern loss, and PRP has also been studied in female patients with encouraging results. A consultation at BIOTOPE CLINIC will help determine which options are appropriate for your specific presentation and history.\"}}]}<\/script><\/p>\n<h2>What Is AGA, and Why Does It Progress Without Treatment?<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_9755382_1794266527.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 What Is AGA, and Why Does It Progress Without Treatment\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 What Is AGA, and Why Does It Progress Without Treatment\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>AGA is caused by dihydrotestosterone (DHT) shortening the hair follicle growth cycle in genetically susceptible individuals, producing progressive miniaturisation that is essentially permanent without intervention.<\/strong><\/p>\n<p>Testosterone is converted into DHT by the enzyme 5-alpha reductase. DHT then binds to androgen receptors in hair follicles, gradually shrinking them. Each successive growth cycle produces a shorter, finer hair until the follicle stops producing visible strands entirely. The process follows predictable patterns in men \u2014 frontal recession and vertex (crown) thinning \u2014 typically staged using the Norwood-Hamilton scale.<\/p>\n<p>The practical implication is straightforward: because follicle miniaturisation is progressive and cumulative, the earlier a patient begins treatment, the larger the follicle pool available to respond. Waiting is not neutral \u2014 it narrows the therapeutic window for every available approach, pharmacological or regenerative.<\/p>\n<h2>Finasteride and Minoxidil: What the Evidence Shows<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_28994388_1794266528.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Finasteride and Minoxidil: What the Evidence Shows\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Finasteride and Minoxidil: What the Evidence Shows\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>Finasteride and minoxidil are the two pharmacological agents with the most robust clinical evidence for AGA. Both are available in Japan as self-pay treatments, and both require continued use to maintain results.<\/strong><\/p>\n<h3>Finasteride<\/h3>\n<p>Finasteride (1 mg daily) blocks 5-alpha reductase type II, reducing DHT levels in the scalp and serum by approximately 60\u201370%. A 2025 review in the <em>Annals of Dermatology<\/em> (Shin &amp; Huh) reported that 85.7% of male patients showed measurable improvement over five years of treatment, with the vertex area responding more favourably than the frontal hairline. Benefits typically become visible within six months, and sustained outcomes have been documented at the ten-year mark.<\/p>\n<p>Finasteride was approved in Japan by the Ministry of Health, Labour and Welfare in 2005 (marketed as Propecia), and generic formulations have been widely available since 2015. It is a self-pay treatment \u2014 it falls outside Japan&#8217;s national health insurance scheme. The most discussed risk is sexual side effects (reduced libido, erectile difficulty). A pooled analysis found the relative risk of sexual dysfunction at 1.66 (95% CI, 1.20\u20132.30), though the absolute incidence is low and most side effects are reversible upon discontinuation.<\/p>\n<h3>Minoxidil \u2014 Topical and Oral<\/h3>\n<p>Minoxidil is a vasodilator that prolongs the anagen (active growth) phase of the hair cycle. The topical 5% formulation has been a first-line option for decades. A 2025 review in the <em>Annals of Dermatology<\/em> confirmed that 5% foam applied once daily is non-inferior to the classic 2% solution applied twice daily \u2014 an important practical improvement for adherence.<\/p>\n<p>Low-dose oral minoxidil (typically 0.625\u20132.5 mg daily in men) is an off-label but increasingly evidence-supported option. A randomised clinical trial published in <em>JAMA Dermatology<\/em> in 2024 found that oral and topical formulations produce comparable improvements in hair density. The main trade-off with oral administration is a higher rate of hypertrichosis (unwanted body hair growth), occurring in approximately 10\u201320% of patients at higher doses, as well as occasional lightheadedness and fluid retention.<\/p>\n<h3>The Combined Approach<\/h3>\n<p>A 12-month retrospective service evaluation published in the <em>British Journal of Dermatology<\/em> reviewed 502 men using combined low-dose oral minoxidil and oral finasteride. It found that 92.4% were stable or improved and 57.4% demonstrated overt regrowth \u2014 results notably stronger than those reported for either drug used alone. Combined pharmacotherapy is a practical first-line pathway for men presenting with moderate-to-advanced AGA who want the most robust pharmacological response.<\/p>\n<h2>Regenerative Alternatives for AGA Available in Tokyo<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_28994390_1794266529.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Regenerative Alternatives for AGA Available in Tokyo\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Regenerative Alternatives for AGA Available in Tokyo\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>Regenerative approaches \u2014 most notably platelet-rich plasma (PRP) and exosome therapy \u2014 aim to stimulate dormant follicles using biological signals derived from the patient&#8217;s own blood or from stem-cell-conditioned material, without the systemic hormone-modulating effects of 5-alpha reductase inhibitors.<\/strong><\/p>\n<h3>Platelet-Rich Plasma (PRP) Therapy<\/h3>\n<p>PRP therapy involves drawing a small volume of the patient&#8217;s blood, centrifuging it to concentrate platelets and their associated growth factors (including PDGF, VEGF, and IGF-1), then injecting the resulting preparation into the scalp. These growth factors stimulate dermal papilla cells, prolong the anagen phase, and are thought to improve scalp vascularity.<\/p>\n<p>A comprehensive evaluation published in <em>Cureus<\/em> in January 2025 \u2014 drawing on more than a dozen controlled studies \u2014 found that PRP increased mean hair density by approximately 28 hairs\/cm\u00b2. Patient satisfaction rates across reviewed trials ranged from 78% to 92%, with one included study reporting that 91.4% of PRP-treated patients noted clinical improvement. Standard protocols involve 3\u20136 monthly sessions, often followed by maintenance injections every three to six months. Because PRP uses the patient&#8217;s own blood, the risk of systemic side effects is minimal; mild scalp tenderness for 24\u201348 hours after injection is the most commonly reported response.<\/p>\n<h3>Exosome and Stem-Cell-Derived Therapy<\/h3>\n<p>Exosome therapy is a newer modality in which nanoparticles derived from mesenchymal stem cells \u2014 containing messenger RNA, proteins, and signalling molecules \u2014 are applied to or injected into the scalp. Exosomes are understood to activate the Wnt\/\u03b2-catenin pathway and stimulate dermal papilla cells, two processes central to hair follicle cycling and regeneration.<\/p>\n<p>A 2025 systematic review of 11 studies (including two randomised trials) reported gains of approximately 9.5\u201335 hairs\/cm\u00b2 following exosome treatment for AGA. The evidence base is earlier-stage than that for PRP, and no approved exosome product for hair loss currently exists in Japan or internationally. In Japan, these treatments are conducted under the Act on the Safety of Regenerative Medicine (\u518d\u751f\u533b\u7642\u7b49\u5b89\u5168\u6027\u78ba\u4fdd\u6cd5), which requires clinics to file a provision plan with the Ministry of Health, Labour and Welfare. For patients unwilling to use hormonal agents or seeking to combine biological regeneration with pharmacotherapy, exosome therapy represents an evolving option \u2014 particularly for early-stage hair loss where the follicle pool is still active.<\/p>\n<h2>Pharmacotherapy vs Regenerative Approaches: A Side-by-Side Comparison<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_14547030_1794266531.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Pharmacotherapy vs Regenerative Approaches: A Side-by-Side C\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Pharmacotherapy vs Regenerative Approaches: A Side-by-Side C\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>No single treatment suits every patient. The comparison below summarises the key practical differences to help guide an informed discussion with your physician.<\/strong><\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:20px 0;font-size:0.95em;border:1px solid #ccc;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #ccc;padding:10px 12px;background:#f1faf3;text-align:left;font-weight:bold;\">Factor<\/th>\n<th style=\"border:1px solid #ccc;padding:10px 12px;background:#f1faf3;text-align:left;font-weight:bold;\">Finasteride (oral)<\/th>\n<th style=\"border:1px solid #ccc;padding:10px 12px;background:#f1faf3;text-align:left;font-weight:bold;\">Minoxidil (topical \/ oral)<\/th>\n<th style=\"border:1px solid #ccc;padding:10px 12px;background:#f1faf3;text-align:left;font-weight:bold;\">PRP<\/th>\n<th style=\"border:1px solid #ccc;padding:10px 12px;background:#f1faf3;text-align:left;font-weight:bold;\">Exosome Therapy<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Primary mechanism<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Blocks DHT via 5-alpha reductase inhibition<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Vasodilator; prolongs anagen phase<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Growth factor stimulation of dermal papilla<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Stem-cell-derived Wnt\/\u03b2-catenin activation<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Japan regulatory status<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">MHLW-approved; self-pay<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Topical: OTC available; oral: prescription, off-label<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Procedure; no specific drug approval required<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Under MHLW regenerative medicine provision plan<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Key efficacy signal<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">85.7% improvement over 5 years<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Comparable to finasteride; 92.4% stable\/improved in combination<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">+28 hairs\/cm\u00b2 mean; 78\u201392% patient satisfaction<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">+9.5\u201335 hairs\/cm\u00b2; evidence still emerging<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Main side-effect risk<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Sexual dysfunction (RR 1.66; reversible)<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Hypertrichosis (oral); scalp irritation (topical)<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Minimal \u2014 autologous origin; mild tenderness 24\u201348 h<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Mild redness \/ itching at injection site<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Treatment frequency<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Daily pill, indefinite<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Daily application or tablet, indefinite<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">3\u20136 initial sessions; maintenance every 3\u20136 months<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Variable; protocols vary by provider<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Best suited for<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Moderate to advanced AGA, Norwood II\u2013VI<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">All stages; first-line or adjunct<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Early to moderate AGA; adjunct to pharmacotherapy<\/td>\n<td style=\"border:1px solid #ccc;padding:10px 12px;vertical-align:top;\">Early AGA; patients avoiding hormonal agents<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>AGA Treatment Costs in Tokyo<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_23349891_1794266532.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 AGA Treatment Costs in Tokyo\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 AGA Treatment Costs in Tokyo\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>All AGA pharmacotherapy in Japan is self-pay \u2014 none of it is covered by national health insurance \u2014 and in-clinic regenerative procedures carry separate per-session fees that vary between providers and protocols.<\/strong><\/p>\n<p>Generic finasteride is widely available in Japan at a significantly lower cost than the original branded Propecia, making long-term pharmacotherapy more accessible than it was a decade ago. Topical minoxidil is sold over the counter at pharmacies; oral minoxidil requires a physician prescription. Medication costs should be confirmed at the time of prescription, as prices fluctuate.<\/p>\n<p>PRP and exosome sessions are priced on a per-session basis in Tokyo, with multi-session packages commonly offered to cover the initial treatment course. Fees differ based on the preparation technique, the volume of growth-factor concentrate used, and whether adjunct treatments such as microneedling are combined.<\/p>\n<p>Please see the clinic&#8217;s official price page or contact us for a current quote. For an accurate quote tailored to your specific hair loss stage and treatment goals, please book a consultation.<\/p>\n<div class=\"kjmc-en-booking-inline\" style=\"background:#f7fbf7;border:1px solid #d5e6d8;border-radius:10px;padding:16px 20px;margin:26px 0;text-align:center;\">\n<p style=\"margin:0 0 12px;color:#1a3a1f;font-size:0.95em;line-height:1.65;\"><strong>Have a question about this treatment?<\/strong><br \/>Message us on LINE or WhatsApp \u2014 our English-speaking team usually replies the same day.<\/p>\n<p style=\"margin:0;line-height:1;\">\n<a href=\"https:\/\/line.me\/R\/ti\/p\/@710uitns?ts=05311801&#038;oat_content=url#~\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;gap:8px;background:#06C755;color:#fff;padding:10px 20px;border-radius:8px;text-decoration:none;font-weight:bold;font-size:0.92em;margin:4px 6px;white-space:nowrap;vertical-align:middle;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M19.365 9.863c.349 0 .63.285.63.631 0 .345-.281.63-.63.63H17.61v1.125h1.755c.349 0 .63.283.63.63 0 .344-.281.629-.63.629h-2.386c-.345 0-.627-.285-.627-.629V8.108c0-.345.282-.63.63-.63h2.386c.346 0 .627.285.627.63 0 .349-.281.63-.63.63H17.61v1.125h1.755zm-3.855 3.016c0 .27-.174.51-.432.596-.064.021-.133.031-.199.031-.211 0-.391-.09-.51-.25l-2.443-3.317v2.94c0 .344-.279.629-.631.629-.346 0-.626-.285-.626-.629V8.108c0-.27.173-.51.43-.595.06-.023.136-.033.194-.033.195 0 .375.104.495.254l2.462 3.33V8.108c0-.345.282-.63.63-.63.345 0 .63.285.63.63v4.771zm-5.741 0c0 .344-.282.629-.631.629-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.349 0 .631.285.631.63v4.771zm-2.466.629H4.917c-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.348 0 .63.285.63.63v4.141h1.756c.348 0 .629.283.629.63 0 .344-.282.629-.629.629M24 10.314C24 4.943 18.615.572 12 .572S0 4.943 0 10.314c0 4.811 4.27 8.842 10.035 9.608.391.082.923.258 1.058.59.12.301.079.766.038 1.08l-.164 1.02c-.045.301-.24 1.186 1.049.645 1.291-.539 6.916-4.078 9.436-6.975C23.176 14.393 24 12.458 24 10.314\"\/><\/svg>Book via LINE<\/a><br \/>\n<a href=\"https:\/\/whatsapp.com\/channel\/0029VbCA1v85K3zY4MLX2a1h\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;gap:8px;background:#25D366;color:#fff;padding:10px 20px;border-radius:8px;text-decoration:none;font-weight:bold;font-size:0.92em;margin:4px 6px;white-space:nowrap;vertical-align:middle;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M.057 24l1.687-6.163a11.867 11.867 0 0 1-1.587-5.946C.16 5.335 5.495 0 12.05 0a11.817 11.817 0 0 1 8.413 3.488 11.824 11.824 0 0 1 3.48 8.414c-.003 6.557-5.338 11.892-11.893 11.892a11.9 11.9 0 0 1-5.688-1.448L.057 24zm6.597-3.807c1.676.995 3.276 1.591 5.392 1.592 5.448 0 9.886-4.434 9.889-9.885.002-5.462-4.415-9.89-9.881-9.892-5.452 0-9.887 4.434-9.889 9.884a9.86 9.86 0 0 0 1.515 5.26l-.999 3.648 3.973-1.607zm11.387-5.464c-.074-.124-.272-.198-.57-.347-.297-.149-1.758-.868-2.031-.967-.272-.099-.47-.149-.669.149-.198.297-.768.967-.941 1.165-.173.198-.347.223-.644.074-.297-.149-1.255-.462-2.39-1.475-.883-.788-1.48-1.761-1.653-2.059-.173-.297-.018-.458.13-.606.134-.133.297-.347.446-.521.151-.172.2-.296.3-.495.099-.198.05-.371-.025-.52-.075-.149-.669-1.611-.916-2.206-.242-.579-.487-.5-.669-.51l-.57-.01c-.198 0-.52.074-.792.372-.272.297-1.04 1.016-1.04 2.479 0 1.462 1.065 2.875 1.213 3.074.149.198 2.095 3.2 5.076 4.487.709.306 1.263.489 1.694.626.712.226 1.36.194 1.872.118.571-.085 1.758-.719 2.006-1.413.248-.694.248-1.289.173-1.413z\"\/><\/svg>Message on WhatsApp<\/a>\n<\/p>\n<\/div>\n<h2>Who Is and Is Not a Good Candidate for Regenerative AGA Treatment?<\/h2>\n<figure style=\"margin: 1.5em 0;\"><img decoding=\"async\" src=\"https:\/\/kojihifu.com\/english\/wp-content\/uploads\/2026\/11\/pexels_7320791_1794266534.webp\" alt=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Who Is and Is Not a Good Candidate for Regenerative AGA Trea\" title=\"AGA vs finasteride and minoxidil: regenerative alt \u2014 Who Is and Is Not a Good Candidate for Regenerative AGA Trea\" loading=\"lazy\" style=\"width:100%;max-width:100%;height:auto;border-radius:8px;\" \/><\/figure>\n<p><strong>Regenerative approaches work best in patients with active but miniaturised follicles \u2014 that is, early to moderate hair loss where follicles are still present and potentially responsive to growth-factor stimulation.<\/strong><\/p>\n<h3>What BIOTOPE CLINIC Sees Most Often Among Patients Enquiring About Regenerative Options<\/h3>\n<p>Patients consulting at BIOTOPE CLINIC in Shirokanedai about regenerative AGA treatment typically fall into one of three profiles: those who have been using finasteride for one to two years and want to enhance or accelerate their results; those who are unwilling to use 5-alpha reductase inhibitors due to concerns about sexual side effects; and those at an early Norwood stage who want to intervene before pharmacotherapy becomes indispensable.<\/p>\n<p>The team uses the initial consultation to assess the stage of hair loss, review medical history, and determine whether the patient&#8217;s remaining follicle pool is a realistic substrate for regenerative stimulation. Patients who are <strong>not<\/strong> well-suited to regenerative-only approaches include those with advanced-stage hair loss (Norwood V\u2013VII) where the follicular reserve is severely depleted, those with active scalp inflammatory conditions (which should be treated first), patients on anticoagulant medications (relevant for PRP), and anyone expecting immediate or guaranteed regrowth. The realistic timeline for measurable regenerative response spans six to twelve months.<\/p>\n<p>At BIOTOPE CLINIC, orthomolecular (nutritional) therapy and IV drip therapy \u2014 including high-dose vitamin C and glutathione infusions \u2014 are available within the clinic&#8217;s preventive medicine programme as a supportive measure to optimise the cellular environment for follicle recovery. These are not primary AGA therapies, but they can complement both pharmacological and regenerative pathways in patients where nutritional status may be a contributing factor. Ask about these options during a consultation with Dr. Karibe&#8217;s team.<\/p>\n<h2>Common Misconceptions About AGA Treatment<\/h2>\n<p><strong>Several widespread misunderstandings lead patients to delay treatment, choose the wrong approach, or abandon an effective therapy too soon.<\/strong><\/p>\n<p><strong>Misconception: Stopping finasteride will accelerate hair loss beyond the natural baseline.<\/strong> This fear is not supported by clinical evidence. Studies indicate that hair loss following finasteride discontinuation returns to approximately the trajectory it would have followed had treatment never started \u2014 not to an accelerated or worsened state. The concern likely arises from the contrast between years of stabilisation and the visible resumption of loss, but no rebound beyond the natural progression rate has been demonstrated in published trials (Shin &amp; Huh, Annals of Dermatology, 2025). That said, any regrowth or density gained during treatment will be gradually lost if the hormonal driver (DHT) is no longer suppressed.<\/p>\n<p><strong>Misconception: PRP is a one-time cure for AGA.<\/strong> PRP is not a single-treatment solution, nor does it address the underlying genetic susceptibility of follicles to DHT. Maintenance sessions \u2014 typically every three to six months after the initial course \u2014 are needed to sustain results. Patients who discontinue all treatment, whether pharmacological or regenerative, should expect the natural progression of their AGA to resume over time.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<dl class=\"kj-faq\">\n<dt>Q. Can I combine finasteride or minoxidil with PRP?<\/dt>\n<dd>Yes. Combination approaches are well-supported in clinical literature. Pharmacotherapy addresses the hormonal driver (DHT suppression or vascular stimulation), while PRP provides growth factor stimulation to the follicle environment. Studies suggest that adding PRP to standard medications improves hair density and thickness more than either intervention alone. Your physician at BIOTOPE CLINIC can advise on scheduling and protocols for your specific situation.<\/dd>\n<dt>Q. How long before I see results from PRP for hair loss?<\/dt>\n<dd>Most patients in clinical trials noticed measurable improvement at three to six months after their first session. Because hair cycles are inherently slow \u2014 the anagen phase for scalp hair lasts two to six years \u2014 the full response to an initial course of three to four monthly sessions is typically evaluated at six to nine months. Visible change before twelve weeks is uncommon, and patience is an essential part of the process.<\/dd>\n<dt>Q. Is exosome therapy for AGA covered by Japan&#8217;s health insurance?<\/dt>\n<dd>No. Exosome and stem-cell-derived treatments are conducted in Japan under the Act on the Safety of Regenerative Medicine and fall entirely outside the national health insurance scheme. They are self-pay, and costs should be confirmed with the treating clinic at consultation. This is true for all AGA pharmacotherapy as well \u2014 finasteride and minoxidil are also self-pay in Japan.<\/dd>\n<dt>Q. I am a woman experiencing hair thinning. Are these treatments relevant?<\/dt>\n<dd>Female-pattern hair loss (FAGA) has a distinct hormonal profile from male AGA, and oral finasteride is not indicated for women of childbearing potential in Japan. Topical minoxidil does have evidence in female-pattern loss, and PRP has also been studied in female patients with encouraging results. A consultation at BIOTOPE CLINIC will help determine which options are appropriate for your specific presentation and history.<\/dd>\n<\/dl>\n<div class=\"kjmc-en-booking-inline\" style=\"background:#f7fbf7;border:1px solid #d5e6d8;border-radius:10px;padding:16px 20px;margin:26px 0;text-align:center;\">\n<p style=\"margin:0 0 12px;color:#1a3a1f;font-size:0.95em;line-height:1.65;\"><strong>Have a question about this treatment?<\/strong><br \/>Message us on LINE or WhatsApp \u2014 our English-speaking team usually replies the same day.<\/p>\n<p style=\"margin:0;line-height:1;\">\n<a href=\"https:\/\/line.me\/R\/ti\/p\/@710uitns?ts=05311801&#038;oat_content=url#~\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;gap:8px;background:#06C755;color:#fff;padding:10px 20px;border-radius:8px;text-decoration:none;font-weight:bold;font-size:0.92em;margin:4px 6px;white-space:nowrap;vertical-align:middle;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M19.365 9.863c.349 0 .63.285.63.631 0 .345-.281.63-.63.63H17.61v1.125h1.755c.349 0 .63.283.63.63 0 .344-.281.629-.63.629h-2.386c-.345 0-.627-.285-.627-.629V8.108c0-.345.282-.63.63-.63h2.386c.346 0 .627.285.627.63 0 .349-.281.63-.63.63H17.61v1.125h1.755zm-3.855 3.016c0 .27-.174.51-.432.596-.064.021-.133.031-.199.031-.211 0-.391-.09-.51-.25l-2.443-3.317v2.94c0 .344-.279.629-.631.629-.346 0-.626-.285-.626-.629V8.108c0-.27.173-.51.43-.595.06-.023.136-.033.194-.033.195 0 .375.104.495.254l2.462 3.33V8.108c0-.345.282-.63.63-.63.345 0 .63.285.63.63v4.771zm-5.741 0c0 .344-.282.629-.631.629-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.349 0 .631.285.631.63v4.771zm-2.466.629H4.917c-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.348 0 .63.285.63.63v4.141h1.756c.348 0 .629.283.629.63 0 .344-.282.629-.629.629M24 10.314C24 4.943 18.615.572 12 .572S0 4.943 0 10.314c0 4.811 4.27 8.842 10.035 9.608.391.082.923.258 1.058.59.12.301.079.766.038 1.08l-.164 1.02c-.045.301-.24 1.186 1.049.645 1.291-.539 6.916-4.078 9.436-6.975C23.176 14.393 24 12.458 24 10.314\"\/><\/svg>Book via LINE<\/a><br \/>\n<a href=\"https:\/\/whatsapp.com\/channel\/0029VbCA1v85K3zY4MLX2a1h\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;gap:8px;background:#25D366;color:#fff;padding:10px 20px;border-radius:8px;text-decoration:none;font-weight:bold;font-size:0.92em;margin:4px 6px;white-space:nowrap;vertical-align:middle;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M.057 24l1.687-6.163a11.867 11.867 0 0 1-1.587-5.946C.16 5.335 5.495 0 12.05 0a11.817 11.817 0 0 1 8.413 3.488 11.824 11.824 0 0 1 3.48 8.414c-.003 6.557-5.338 11.892-11.893 11.892a11.9 11.9 0 0 1-5.688-1.448L.057 24zm6.597-3.807c1.676.995 3.276 1.591 5.392 1.592 5.448 0 9.886-4.434 9.889-9.885.002-5.462-4.415-9.89-9.881-9.892-5.452 0-9.887 4.434-9.889 9.884a9.86 9.86 0 0 0 1.515 5.26l-.999 3.648 3.973-1.607zm11.387-5.464c-.074-.124-.272-.198-.57-.347-.297-.149-1.758-.868-2.031-.967-.272-.099-.47-.149-.669.149-.198.297-.768.967-.941 1.165-.173.198-.347.223-.644.074-.297-.149-1.255-.462-2.39-1.475-.883-.788-1.48-1.761-1.653-2.059-.173-.297-.018-.458.13-.606.134-.133.297-.347.446-.521.151-.172.2-.296.3-.495.099-.198.05-.371-.025-.52-.075-.149-.669-1.611-.916-2.206-.242-.579-.487-.5-.669-.51l-.57-.01c-.198 0-.52.074-.792.372-.272.297-1.04 1.016-1.04 2.479 0 1.462 1.065 2.875 1.213 3.074.149.198 2.095 3.2 5.076 4.487.709.306 1.263.489 1.694.626.712.226 1.36.194 1.872.118.571-.085 1.758-.719 2.006-1.413.248-.694.248-1.289.173-1.413z\"\/><\/svg>Message on WhatsApp<\/a>\n<\/p>\n<\/div>\n<h2>Where to Get AGA Treatment in Tokyo<\/h2>\n<p><strong>Within our clinic group, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology &amp; Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Jun Karibe&#8217;s team. AGA \u2014 including both pharmacotherapy and regenerative options \u2014 is handled at BIOTOPE CLINIC in Shirokanedai, the group&#8217;s dedicated cosmetic, plastic surgery, and men&#8217;s health branch. Bookings and enquiries in English: LINE or WhatsApp.<\/strong><\/p>\n<p>BIOTOPE CLINIC in Shirokanedai, Minato-ku, is Dr. Karibe&#8217;s primary base for men&#8217;s health consultations including AGA. The team can guide patients through the full spectrum of options: finasteride and minoxidil (including generic availability), regenerative in-clinic procedures, and supportive preventive medicine. English-language appointments are available, and no Japanese-language ability is required.<\/p>\n<p>Kojimachi Dermatology &amp; Plastic Surgery Clinic in Ichigaya, Chiyoda-ku, is the group&#8217;s main office and focuses on insurance-covered general dermatology and plastic surgery. If your concern involves a scalp condition that may warrant an insurance-eligible assessment \u2014 such as alopecia areata, seborrhoeic dermatitis, or inflammatory scalp disease \u2014 that clinic is the appropriate starting point and also offers English-language consultation.<\/p>\n<h2>Summary<\/h2>\n<p>AGA is progressive, but the range of treatment options available in Tokyo in 2026 is broader and more evidence-based than ever. Finasteride and minoxidil remain the most robust pharmacological options, with decades of data supporting their efficacy, and combination therapy yields the strongest results in this category. Regenerative approaches \u2014 particularly PRP and emerging exosome therapy \u2014 offer a valuable alternative or adjunct, especially for patients seeking to avoid systemic hormone effects or to enhance their pharmacotherapy results. Neither pathway is a one-time fix; both require a consistent, long-term commitment and realistic expectations about timeline.<\/p>\n<p>If you have questions about AGA or the treatments described in this article, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology &amp; Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Karibe and his team. AGA treatment is primarily handled at BIOTOPE CLINIC in Shirokanedai. English enquiries: LINE or WhatsApp.<\/p>\n<div class=\"kjmc-en-booking-box\" style=\"background:linear-gradient(135deg,#f1faf3 0%,#e6f3ea 100%);border-radius:14px;padding:32px 24px;margin:36px 0 24px;border:1px solid #c5dccd;text-align:center;\">\n<h3 style=\"margin:0 0 8px;color:#3a6e3a;border:none;padding:0;font-size:1.3em;\">24\/7 Consultation &amp; Booking<\/h3>\n<div style=\"width:48px;height:2px;background:#3a6e3a;margin:0 auto 22px;\"><\/div>\n<p style=\"margin:0 0 12px;color:#1a3a1f;font-size:1.1em;font-weight:bold;\">Book a Consultation or Treatment<\/p>\n<p style=\"margin:0 0 24px;color:#2c4a35;line-height:1.75;\">Our English-speaking team responds via LINE or WhatsApp \u2014 usually the same day.<\/p>\n<p style=\"margin:0 0 10px;line-height:1;\">\n<a href=\"https:\/\/line.me\/R\/ti\/p\/@710uitns?ts=05311801&#038;oat_content=url#~\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;justify-content:center;gap:10px;background:#06C755;color:#fff;padding:14px 32px;border-radius:10px;text-decoration:none;font-weight:bold;font-size:1.02em;box-shadow:0 2px 8px rgba(6,199,85,0.25);min-width:240px;white-space:nowrap;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M19.365 9.863c.349 0 .63.285.63.631 0 .345-.281.63-.63.63H17.61v1.125h1.755c.349 0 .63.283.63.63 0 .344-.281.629-.63.629h-2.386c-.345 0-.627-.285-.627-.629V8.108c0-.345.282-.63.63-.63h2.386c.346 0 .627.285.627.63 0 .349-.281.63-.63.63H17.61v1.125h1.755zm-3.855 3.016c0 .27-.174.51-.432.596-.064.021-.133.031-.199.031-.211 0-.391-.09-.51-.25l-2.443-3.317v2.94c0 .344-.279.629-.631.629-.346 0-.626-.285-.626-.629V8.108c0-.27.173-.51.43-.595.06-.023.136-.033.194-.033.195 0 .375.104.495.254l2.462 3.33V8.108c0-.345.282-.63.63-.63.345 0 .63.285.63.63v4.771zm-5.741 0c0 .344-.282.629-.631.629-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.349 0 .631.285.631.63v4.771zm-2.466.629H4.917c-.345 0-.63-.285-.63-.629V8.108c0-.345.285-.63.63-.63.348 0 .63.285.63.63v4.141h1.756c.348 0 .629.283.629.63 0 .344-.282.629-.629.629M24 10.314C24 4.943 18.615.572 12 .572S0 4.943 0 10.314c0 4.811 4.27 8.842 10.035 9.608.391.082.923.258 1.058.59.12.301.079.766.038 1.08l-.164 1.02c-.045.301-.24 1.186 1.049.645 1.291-.539 6.916-4.078 9.436-6.975C23.176 14.393 24 12.458 24 10.314\"\/><\/svg>Book via LINE<\/a>\n<\/p>\n<p style=\"margin:0;line-height:1;\">\n<a href=\"https:\/\/whatsapp.com\/channel\/0029VbCA1v85K3zY4MLX2a1h\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-flex;align-items:center;justify-content:center;gap:10px;background:#25D366;color:#fff;padding:14px 32px;border-radius:10px;text-decoration:none;font-weight:bold;font-size:1.02em;box-shadow:0 2px 8px rgba(37,211,102,0.25);min-width:240px;white-space:nowrap;\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"#fff\" aria-hidden=\"true\" style=\"flex-shrink:0;\"><path d=\"M.057 24l1.687-6.163a11.867 11.867 0 0 1-1.587-5.946C.16 5.335 5.495 0 12.05 0a11.817 11.817 0 0 1 8.413 3.488 11.824 11.824 0 0 1 3.48 8.414c-.003 6.557-5.338 11.892-11.893 11.892a11.9 11.9 0 0 1-5.688-1.448L.057 24zm6.597-3.807c1.676.995 3.276 1.591 5.392 1.592 5.448 0 9.886-4.434 9.889-9.885.002-5.462-4.415-9.89-9.881-9.892-5.452 0-9.887 4.434-9.889 9.884a9.86 9.86 0 0 0 1.515 5.26l-.999 3.648 3.973-1.607zm11.387-5.464c-.074-.124-.272-.198-.57-.347-.297-.149-1.758-.868-2.031-.967-.272-.099-.47-.149-.669.149-.198.297-.768.967-.941 1.165-.173.198-.347.223-.644.074-.297-.149-1.255-.462-2.39-1.475-.883-.788-1.48-1.761-1.653-2.059-.173-.297-.018-.458.13-.606.134-.133.297-.347.446-.521.151-.172.2-.296.3-.495.099-.198.05-.371-.025-.52-.075-.149-.669-1.611-.916-2.206-.242-.579-.487-.5-.669-.51l-.57-.01c-.198 0-.52.074-.792.372-.272.297-1.04 1.016-1.04 2.479 0 1.462 1.065 2.875 1.213 3.074.149.198 2.095 3.2 5.076 4.487.709.306 1.263.489 1.694.626.712.226 1.36.194 1.872.118.571-.085 1.758-.719 2.006-1.413.248-.694.248-1.289.173-1.413z\"\/><\/svg>Message on WhatsApp<\/a>\n<\/p>\n<\/div>\n<h2>References<\/h2>\n<ol>\n<li>Shin J-W, Huh C-H. Updates in Treatment for Androgenetic Alopecia. Annals of Dermatology. 2025.<\/li>\n<li>Lopes-Silva et al. Platelet-Rich Plasma Effectiveness in Treating Androgenetic Alopecia: A Comprehensive Evaluation. Cureus. 2025.<\/li>\n<li>Walsh L et al. Pharmacological efficacy of low-dose oral minoxidil\u2013finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation. British Journal of Dermatology. 2025.<\/li>\n<li>Photiou L et al. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatology. 2024.<\/li>\n<li>Zhong et al. Research Progress on Platelet-Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia. Journal of Cosmetic Dermatology. 2026.<\/li>\n<\/ol>\n<h2>Related Articles<\/h2>\n<p>You may also find these articles useful.<\/p>\n<ul>\n<li><a href=\"https:\/\/kojihifu.com\/english\/aga-stem-cell-supernatant-tokyo\/\" target=\"_blank\" rel=\"noopener\">AGA Treatment Tokyo: Stem Cell Supernatant Hair Regrowth<\/a><\/li>\n<li><a href=\"https:\/\/kojihifu.com\/english\/exosome-hair-therapy-tokyo\/\" target=\"_blank\" rel=\"noopener\">Exosome Hair Therapy in Tokyo vs PRP and Mesotherapy<\/a><\/li>\n<li><a href=\"https:\/\/kojihifu.com\/english\/dutasteride-japan-dosage-brands\/\" target=\"_blank\" rel=\"noopener\">Dutasteride 0.5 mg in Japan: Dosage, Brands and Prescribing<\/a><\/li>\n<li><a href=\"https:\/\/kojihifu.com\/english\/aga-treatment-6-months-results\/\" target=\"_blank\" rel=\"noopener\">AGA Treatment After 6 Months: Realistic Results in Tokyo<\/a><\/li>\n<li><a href=\"https:\/\/kojihifu.com\/english\/hair-loss-treatment-tokyo-aga-expats\/\" target=\"_blank\" rel=\"noopener\">Hair Loss Treatment Tokyo: AGA Options for Expats<\/a><\/li>\n<\/ul>\n<div style=\"margin:2.5em 0 1em;padding:1.5em;border:1px solid #d5d5d5;border-radius:10px;background:#fafafa;font-size:.9em;\">\n<p style=\"font-size:.72em;font-weight:bold;color:#888;margin:0 0 1.2em;letter-spacing:.08em;\">SUPERVISED BY<\/p>\n<div style=\"display:flex;align-items:flex-start;gap:1.2em;flex-wrap:wrap;\">\n<div style=\"flex-shrink:0;text-align:center;min-width:110px;\">\n<img decoding=\"async\" src=\"https:\/\/kojihifu.com\/hon\/wp-content\/uploads\/2022\/01\/photo-karibejun-400-3_re-300x300.jpg\" alt=\"Dr. Jun Karibe MD \u2014 Board-certified Plastic Surgeon, Director of Kojimachi Dermatology &amp; Plastic Surgery Clinic\" style=\"width:100px;height:100px;border-radius:50%;object-fit:cover;object-position:top center;display:block;margin:0 auto;border:3px solid #e0e0e0;\" \/><\/p>\n<p style=\"margin:.6em 0 .1em;font-weight:bold;font-size:.95em;color:#222;\">Dr. Jun Karibe<\/p>\n<p style=\"margin:0 0 .1em;font-size:.75em;color:#999;\">MD<\/p>\n<p style=\"margin:0;font-size:.75em;color:#555;font-weight:bold;\">Director<\/p>\n<\/div>\n<div style=\"flex:1;min-width:200px;\">\n<div style=\"margin-bottom:.75em;background:#fff;border:1px solid #ebebeb;border-radius:6px;padding:.7em 1em;\">\n<p style=\"margin:0 0 .35em;font-size:.78em;font-weight:bold;color:#666;border-bottom:1px solid #f2f2f2;padding-bottom:.3em;\">Education &amp; Career<\/p>\n<div style=\"font-size:.82em;color:#444;line-height:1.75;\">\n<div>Juntendo University School of Medicine<\/div>\n<div>Department of Plastic Surgery, University of Tokyo Hospital<\/div>\n<div>Assistant Professor, Plastic &amp; Cosmetic Surgery, Saitama Medical University<\/div>\n<div>Assistant Professor &amp; Chief Resident, Yamanashi University Hospital<\/div>\n<div>2019: Founded Kojimachi Dermatology &amp; Plastic Surgery Clinic (Ichigaya, Tokyo)<\/div>\n<div>2021: Founded BIOTOPE CLINIC Shirokanedai (Minato-ku, Tokyo)<\/div>\n<\/div>\n<\/div>\n<div style=\"margin-bottom:.75em;background:#fff;border:1px solid #ebebeb;border-radius:6px;padding:.7em 1em;\">\n<p style=\"margin:0 0 .35em;font-size:.78em;font-weight:bold;color:#666;border-bottom:1px solid #f2f2f2;padding-bottom:.3em;\">Certifications<\/p>\n<div style=\"font-size:.82em;color:#444;line-height:1.75;\">\n<div>Board-certified Plastic Surgeon \u2014 Japan Society of Plastic and Reconstructive Surgery<\/div>\n<div>Specialist \u2014 Japan Society of Anti-Aging Medicine<\/div>\n<div>Certified Industrial Physician \u2014 Japan Medical Association<\/div>\n<div>Allergan VST-certified Injector (Botox &amp; Hyaluronic Acid)<\/div>\n<\/div>\n<\/div>\n<div style=\"background:#fff;border:1px solid #ebebeb;border-radius:6px;padding:.7em 1em;\">\n<p style=\"margin:0 0 .35em;font-size:.78em;font-weight:bold;color:#666;border-bottom:1px solid #f2f2f2;padding-bottom:.3em;\">Awards<\/p>\n<div style=\"font-size:.82em;color:#444;line-height:1.75;\">\n<div>Best Presentation Award \u2014 Dept. of Plastic Surgery, University of Tokyo (2016)<\/div>\n<div>Excellence Award \u2014 Japan Society of Plastic and Reconstructive Surgery (2018)<\/div>\n<div>Featured Presentation \u2014 ASPS Annual Scientific Meeting, USA (2018)<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div style=\"margin-top:1em;padding-top:.75em;border-top:1px solid #e8e8e8;display:flex;flex-wrap:wrap;align-items:center;gap:.5em;\">\n<a href=\"https:\/\/www.instagram.com\/dr.jun_\/\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"display:inline-block;background:#e1306c;color:#fff;padding:.4em .9em;border-radius:4px;text-decoration:none;font-size:.8em;font-weight:bold;\">Instagram<\/a><\/p>\n<div style=\"margin-top:1em;padding-top:.75em;border-top:1px dashed #d5d5d5;font-size:.78em;color:#555;line-height:1.7;\">\n<p style=\"margin:0 0 .3em;font-size:.72em;font-weight:bold;color:#888;letter-spacing:.08em;\">MEDICAL REVIEW<\/p>\n<div><strong>Jun Karibe, MD<\/strong> &mdash; Board-certified Plastic Surgeon \u2014 Japan Society of Plastic and Reconstructive Surgery<\/div>\n<div>Medical Director, BIOTOPE CLINIC<\/div>\n<div>Last medically reviewed: 2026-11-10<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"AGA hair loss progresses without treatment. Explore finasteride, minoxidil &#038; regenerative hair alternatives at Tokyo clinics. Book a consultation today.","protected":false},"author":4,"featured_media":13571,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,21],"tags":[979,809,442,243,244,246,247,26],"class_list":["post-13572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cosmetic-treatments","category-skin-dermatology","tag-dht","tag-hair-loss","tag-aga","tag-finasteride","tag-minoxidil","tag-regenerative-medicine","tag-androgenetic-alopecia","tag-tokyo-clinic"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/posts\/13572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/comments?post=13572"}],"version-history":[{"count":1,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/posts\/13572\/revisions"}],"predecessor-version":[{"id":13589,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/posts\/13572\/revisions\/13589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/media\/13571"}],"wp:attachment":[{"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/media?parent=13572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/categories?post=13572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kojihifu.com\/english\/wp-json\/wp\/v2\/tags?post=13572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}